These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36456700)

  • 1. Metabolomics in Cell Biology.
    Eraslan Z; Cascante M; Günther UL
    Handb Exp Pharmacol; 2023; 277():181-207. PubMed ID: 36456700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research.
    Emwas AH
    Methods Mol Biol; 2015; 1277():161-93. PubMed ID: 25677154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer.
    Gu H; Pan Z; Xi B; Asiago V; Musselman B; Raftery D
    Anal Chim Acta; 2011 Feb; 686(1-2):57-63. PubMed ID: 21237308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowns and unknowns in metabolomics identified by multidimensional NMR and hybrid MS/NMR methods.
    Bingol K; Brüschweiler R
    Curr Opin Biotechnol; 2017 Feb; 43():17-24. PubMed ID: 27552705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing rigor in NMR-based metabolomics through validated and open source tools.
    Eghbalnia HR; Romero PR; Westler WM; Baskaran K; Ulrich EL; Markley JL
    Curr Opin Biotechnol; 2017 Feb; 43():56-61. PubMed ID: 27643760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective.
    Rankin NJ; Preiss D; Welsh P; Burgess KE; Nelson SM; Lawlor DA; Sattar N
    Atherosclerosis; 2014 Nov; 237(1):287-300. PubMed ID: 25299963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic signature of brain cancer.
    Pandey R; Caflisch L; Lodi A; Brenner AJ; Tiziani S
    Mol Carcinog; 2017 Nov; 56(11):2355-2371. PubMed ID: 28618012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time is ripe: maturation of metabolomics in chronobiology.
    Rhoades SD; Sengupta A; Weljie AM
    Curr Opin Biotechnol; 2017 Feb; 43():70-76. PubMed ID: 27701007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two elephants in the room: new hybrid nuclear magnetic resonance and mass spectrometry approaches for metabolomics.
    Bingol K; Brüschweiler R
    Curr Opin Clin Nutr Metab Care; 2015 Sep; 18(5):471-7. PubMed ID: 26154280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics and its applications in assisted reproductive technology.
    Gao J; Xiao Y
    IET Nanobiotechnol; 2023 Jul; 17(5):399-405. PubMed ID: 37248807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics: a revolution for novel cancer marker identification.
    Bu Q; Huang Y; Yan G; Cen X; Zhao YL
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):266-75. PubMed ID: 22221059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovering New Natural Products Using Metabolomics-Based Approaches.
    de Medeiros LS; de Araújo Júnior MB; Peres EG; da Silva JCI; Bassicheto MC; Di Gioia G; Veiga TAM; Koolen HHF
    Adv Exp Med Biol; 2023; 1439():185-224. PubMed ID: 37843810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of NMR-based metabolomics.
    Markley JL; Brüschweiler R; Edison AS; Eghbalnia HR; Powers R; Raftery D; Wishart DS
    Curr Opin Biotechnol; 2017 Feb; 43():34-40. PubMed ID: 27580257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic Approaches to Study Chemical Exposure-Related Metabolism Alterations in Mammalian Cell Cultures.
    Balcerczyk A; Damblon C; Elena-Herrmann B; Panthu B; Rautureau GJP
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the small molecule studies of osteoarthritis using nuclear magnetic resonance and mass spectroscopy.
    Jaggard MKJ; Boulangé CL; Akhbari P; Vaghela U; Bhattacharya R; Williams HRT; Lindon JC; Gupte CM
    Osteoarthritis Cartilage; 2019 Apr; 27(4):560-570. PubMed ID: 30287397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics.
    Marshall DD; Powers R
    Prog Nucl Magn Reson Spectrosc; 2017 May; 100():1-16. PubMed ID: 28552170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Unknown Metabolomics Mixture Compounds by Combining NMR, MS, and Cheminformatics.
    Leggett A; Wang C; Li DW; Somogyi A; Bruschweiler-Li L; Brüschweiler R
    Methods Enzymol; 2019; 615():407-422. PubMed ID: 30638535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The integration of LC-MS and NMR for the analysis of low molecular weight trace analytes in complex matrices.
    Gathungu RM; Kautz R; Kristal BS; Bird SS; Vouros P
    Mass Spectrom Rev; 2020 Mar; 39(1-2):35-54. PubMed ID: 30024655
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.